Brittany Cody
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Brittany Cody has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Emrah Duman
Department of Radiology, Division of Cardiothoracic Imaging, University of Pittsburgh Medical Center, 203 Lothrop St, EEI Ste 700, Pittsburgh, PA 15213
1 shared publication Iclal Ocak
Department of Radiology, Division of Cardiothoracic Imaging, The University of Chicago, Chicago, Ill
1 shared publication- Omer Onder
Department of Radiology, Division of Cardiothoracic Imaging, University of Pittsburgh Medical Center, 203 Lothrop St, EEI Ste 700, Pittsburgh, PA 15213
1 shared publication - Zehavit Kirshenboim
Division of Diagnostic Imaging, Sheba Medical Center, Tel Hashomer, 2 Derech Sheba St, Ramat Gan 5265601, Israel
1 shared publication
Latest Publications
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (5) , e250100
Understanding Adenocarcinoma of the Lung Developing from Subsolid Nodules and Atypical Pulmonary Cysts
Subsolid nodules and atypical pulmonary cysts can pose diagnostic challenges due to their slow growth and atypical imaging features, and improved understanding of their imaging hallmarks, pathologic correlations, guideline-based recommendations, and risk assessment strategies is essential for accurately identifying pulmonary adenocarcinomas that may arise from these potentially malignant lesions.
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (5) , e250100
Understanding Adenocarcinoma of the Lung Developing from Subsolid Nodules and Atypical Pulmonary Cysts
Subsolid nodules and atypical pulmonary cysts can pose diagnostic challenges due to their slow growth and atypical imaging features, and improved understanding of their imaging hallmarks, pathologic correlations, guideline-based recommendations, and risk assessment strategies is essential for accurately identifying pulmonary adenocarcinomas that may arise from these potentially malignant lesions.